Definium Therapeutics (DFTX) Q2 2026 Earnings

7MayConfirmed
Q4 2025
Q2 2026
-0.78
-0.68
-0.59
-0.49

Details

Expected EPS
-0.492129
Actual EPS
-0.71
Surprise EPS
-0.22
Surprise Percent
+44.27%

Description

Definium Therapeutics (DFTX) has reported earnings of -0.71 per share for Q2 2026.

0 Comments

Share your thoughts